Skip to main content
. 2021 Dec 6;115(3):738–748. doi: 10.1093/ajcn/nqab404

TABLE 2.

Unadjusted effects of prenatal MMS, MQ-LNS, and IFA on continuous child growth outcomes at 24 mo of age1

IFA (n = 718)2 MQ-LNS (n = 735)2 MMS (n = 642)2 MQ-LNS vs. IFA3 MMS vs. IFA3 MQ-LNS vs. MMS3
LAZ –2.53 ± 0.99 –2.49 ± 0.96 –2.60 ± 1.06 0.04 (–0.22, 0.30) –0.07 (–0.33, 0.18) 0.11 (–0.15, 0.38)
WAZ –1.75 ± 1.06 –1.87 ± 1.09 –1.80 ± 1.08 –0.12 (–0.44, 0.19) –0.05 (–0.29, 0.18) –0.07 (–0.38, 0.25)
WLZ –0.59 ± 1.08 –0.80 ± 1.32 –0.64 ± 1.14 –0.21 (–0.69, 0.26) –0.05 (–0.25, 0.15) –0.16 (–0.64, 0.32)
MUAC, cm 13.69 ± 1.13 14.03 ± 1.12 13.52 ± 1.10 0.34 (–0.05, 0.73) –0.16 (–0.48, 0.15) 0.50 (0.10, 0.91)
1

IFA, iron and folic acid; LAZ, length-for-age z score; MMS, multiple micronutrient supplements; MQ-LNS, medium-quantity lipid-based nutrient supplements; MUAC, midupper arm circumference; WAZ, weight-for-age z score; WLZ, weight-for-length z score.

2

Values are means ± SDs.

3

Values are mean differences (95% CIs) derived from generalized linear models. All estimates were unadjusted. SEs were clustered at the village level.